Ikonisys S.A. Logo

Ikonisys S.A.

ALIKO | PA

Overview

Corporate Details

ISIN(s):
FR00140048X2
LEI:
9695000B742KPNDQ4D05
Country:
France
Address:
62 RUE DE CAUMARTIN, 75009 PARIS
Sector:
Health Care
Industry:
Biotechnology

Description

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease. Through its breakthrough fluorescence microscopy platform, Ikonisys continues to develop a stream of oncology tests for a variety of cancers. At the center of the platform is the Ikoniscope20®, a robotic, high-throughput, microscopy system that provides a true “walk away” automated solution. In addition to providing high quality cell images, the platform analyzes the cells of interest, offering an interpretation of the analysis, to facilitate the quick, accurate reporting of the test result.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-02 17:45
Inside Information Statement
Informations privilégiées / Autres communiqués
French 343.4 KB
2025-05-02 17:45
Capital/Financing Update
Inside Information / Other news releases
English 341.3 KB
2025-04-25 17:45
Report Publication Announcement
Informations privilégiées / Autres communiqués
French 285.5 KB
2025-04-25 17:45
Report Publication Announcement
Inside Information / Other news releases
English 262.5 KB
2025-04-03 08:00
Regulatory News Service
Ikonisys SA : Hospitex International lance Urine24, la première plateforme de t…
French 301.6 KB
2025-04-03 08:00
Regulatory News Service
Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary …
English 294.6 KB
2025-03-10 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 313.8 KB
2025-03-10 18:00
Regulatory News Service
Inside Information / Other news releases
English 268.4 KB
2025-02-27 19:17
Inside Information Statement
Informations privilégiées / Autres communiqués
French 342.1 KB
2025-02-27 19:17
Inside Information Statement
Inside Information / Other news releases
English 342.9 KB
2025-01-15 07:30
Inside Information Statement
Inside Information / Other news releases
English 330.9 KB
2025-01-15 07:30
Inside Information Statement
Informations privilégiées / Autres communiqués
French 341.9 KB
2025-01-10 08:10
Inside Information Statement
Informations privilégiées / Autres communiqués
French 281.0 KB
2025-01-10 08:10
Capital/Financing Update
Inside Information / Other news releases
English 311.1 KB
2024-12-31 18:00
Inside Information Statement
Inside Information / Other news releases
English 296.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS
Hiron-Trade Investments & Industrial Buildings Ltd. Israel HRON
Human Stem Cells Institute PJSC Logo Human Stem Cells Institute PJSC Russian Federation ISKJ
Human Xtensions Ltd. Logo Human Xtensions Ltd. Israel HUMX
Hybrigenics SA Logo Hybrigenics SA France ALHYG
Hyloris Pharmaceuticals SA Logo Hyloris Pharmaceuticals SA Belgium HYL
IMCB PJSC Logo IMCB PJSC Russian Federation GEMA
Inify Laboratories AB Logo Inify Laboratories AB Sweden INIFY
Innate Pharma Logo Innate Pharma France IPH
IntegraGen Logo IntegraGen France ALINT